Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

N Engl J Med. 1990 Jan 11;322(2):111-5. doi: 10.1056/NEJM199001113220207.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • 17-alpha-Hydroxyprogesterone
  • Administration, Oral
  • Adrenal Hyperplasia, Congenital* / drug therapy*
  • Adult
  • Amniotic Fluid / analysis
  • Androgens / analysis
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use*
  • Female
  • Fetal Diseases / drug therapy*
  • Genitalia, Female / abnormalities
  • Gestational Age
  • Humans
  • Hydroxyprogesterones / analysis
  • Infant, Newborn
  • Maternal-Fetal Exchange
  • Pregnancy
  • Steroid Hydroxylases / deficiency*
  • Virilism / prevention & control

Substances

  • Androgens
  • Hydroxyprogesterones
  • 17-alpha-Hydroxyprogesterone
  • Dexamethasone
  • Steroid Hydroxylases